Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2453)
All Articles published online
|
Mar 14, 2005 (publication date) through Jun 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cheng YF, Huang TL, Chen TY, Chen YS, Wang CC, Hsu SL, Tsang LLC, Sun PL, Chiu KW, Jawan B, Eng HL, Chen CL. Impact of pre-operative transarterial embolization on the treatment of hepatocellular carcinoma with liver transplantation. World J Gastroenterol 2005; 11(10): 1433-1438 [PMID: 15770717 DOI: 10.3748/wjg.v11.i10.1433] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i10/1433.htm |
| Number | Citing Articles |
| 1 |
Peter Gunvén. Liver embolizations in oncology: A review. Medical Oncology 2008; 25(1): 1 doi: 10.1007/s12032-007-0039-3
|
| 2 |
See Ching Chan, Tan To Cheung, Albert C.Y. Chan, Kenneth S.H. Chok, William W. Sharr, James Y.Y. Fung, Chi Leung Liu, Sheung Tat Fan, Chung Mau Lo. New insights after the first 1000 liver transplantations at The University of Hong Kong. Asian Journal of Surgery 2016; 39(4): 202 doi: 10.1016/j.asjsur.2015.03.018
|
| 3 |
C.-Y. Yu, H.-Y. Ou, C.-C. Weng, T.-L. Huang, T.-Y. Chen, L. Leung-Chit, H.-W. Hsu, C.-L. Chen, Y.-F. Cheng. Drug-Eluting Bead Transarterial Chemoembolization as Bridge Therapy for Hepatocellular Carcinoma Before Living-Donor Liver Transplantation. Transplantation Proceedings 2016; 48(4): 1045 doi: 10.1016/j.transproceed.2015.12.078
|
| 4 |
Esther Raskopf, Sevil Gerceker, Annabelle Vogt, Jens Standop, Tilman Sauerbruch, Volker Schmitz. Plasminogen fragment K1–3 inhibits expression of adhesion molecules and experimental HCC recurrence in the liver. International Journal of Colorectal Disease 2009; 24(7): 837 doi: 10.1007/s00384-009-0652-z
|
| 5 |
Bassel Atassi, Affaan K. Bangash, Ammar Bahrani, Giuseppi Pizzi, Robert J. Lewandowski, Robert K. Ryu, Kent T. Sato, Vanessa L. Gates, Mary F. Mulcahy, Laura Kulik, Frank Miller, Vahid Yaghmai, Ravi Murthy, Andrew Larson, Reed A. Omary, Riad Salem. Multimodality Imaging Following90Y Radioembolization: A Comprehensive Review and Pictorial Essay. RadioGraphics 2008; 28(1): 81 doi: 10.1148/rg.281065721
|
| 6 |
Irene Bargellini, Claudio Vignali, Roberto Cioni, Pasquale Petruzzi, Antonio Cicorelli, Daniela Campani, Paolo De Simone, Franco Filipponi, Carlo Bartolozzi. Hepatocellular Carcinoma: CT for Tumor Response after Transarterial Chemoembolization in Patients Exceeding Milan Criteria—Selection Parameter for Liver Transplantation. Radiology 2010; 255(1): 289 doi: 10.1148/radiol.09090927
|
| 7 |
T. Clark Gamblin, Sydney D. Finkelstein, J. Wallis Marsh. Hepatocellular Carcinoma. 2009; : 467 doi: 10.1007/978-1-60327-376-3_18
|
| 8 |
Laura M. Kulik, Bassel Atassi, Lodewijk van Holsbeeck, Tameem Souman, Robert J. Lewandowski, Mary F. Mulcahy, Russell D. Hunter, Albert A. Nemcek, Michael M. Abecassis, Kenneth G. Haines, Riad Salem. Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation. Journal of Surgical Oncology 2006; 94(7): 572 doi: 10.1002/jso.20609
|
| 9 |
Allan Concejero, Chao-Long Chen, Chih-Chi Wang, Shih-Ho Wang, Chih-Che Lin, Yueh-Wei Liu, Chin-Hsiang Yang, Chee-Chien Yong, Tsan-Shiun Lin, Bruno Jawan, Tung-Liang Huang, Yu-Fan Cheng, Hock-Liew Eng. Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience in Taiwan. Transplantation 2008; 85(3): 398 doi: 10.1097/TP.0b013e3181622ff8
|
| 10 |
C.-Y. Yu, H.-Y. Ou, T.-L. Huang, T.-Y. Chen, L.L.-C. Tsang, C.-L. Chen, Y.-F. Cheng. Hepatocellular Carcinoma Downstaging in Liver Transplantation. Transplantation Proceedings 2012; 44(2): 412 doi: 10.1016/j.transproceed.2012.01.043
|
| 11 |
Y.S. Tong, T.L. Huang, T.Y. Chen, L.L.C. Tsang, H.Y. Ou, C.Y. Yu, H.W. Hsu, L.W. Xiong, C.C. Liao, H.L. Eng, C.L. Chen, Y.F. Cheng. Imaging Validation of Drug-Eluting Beads Transarterial Chemoembolization of Hepatocellular Carcinomas in Living Donor Liver Transplantation. Transplantation Proceedings 2018; 50(9): 2622 doi: 10.1016/j.transproceed.2018.05.012
|
| 12 |
Chao‐Long Chen, Allan M. Concejero. Liver transplantation for hepatocellular carcinoma in the world: the Taiwan experience. Journal of Hepato-Biliary-Pancreatic Sciences 2010; 17(5): 555 doi: 10.1007/s00534-009-0166-7
|
| 13 |
S. Herber, S. Biesterfeld, U. Franz, J. Schneider, J. Thies, M. Schuchmann, C. Düber, M. B. Pitton, G. Otto. Correlation of Multislice CT and Histomorphology in HCC Following TACE: Predictors of Outcome. CardioVascular and Interventional Radiology 2008; 31(4): 768 doi: 10.1007/s00270-007-9270-8
|
| 14 |
Yi‐Chia Chan, Catherine S. Kabiling, Vinod G. Pillai, Gustavo Aguilar, Chih‐Chi Wang, Chao‐Long Chen. Survival Outcome Between Hepatic Resection and Transarterial Embolization for Hepatocellular Carcinoma More Than 10 cm: A Propensity Score Model. World Journal of Surgery 2015; 39(6): 1510 doi: 10.1007/s00268-015-2975-y
|
| 15 |
Kent Sato, Robert J. Lewandowski, James T. Bui, Reed Omary, Russell D. Hunter, Laura Kulik, Mary Mulcahy, David Liu, Howard Chrisman, Scott Resnick, Albert A. Nemcek, Robert Vogelzang, Riad Salem. Treatment of Unresectable Primary and Metastatic Liver Cancer with Yttrium-90 Microspheres (TheraSphere®): Assessment of Hepatic Arterial Embolization. CardioVascular and Interventional Radiology 2006; 29(4): 522 doi: 10.1007/s00270-005-0171-4
|
| 16 |
Xinli Huang, Sen Lu. Impact of preoperative locoregional therapy on recurrence and patient survival following liver transplantation for hepatocellular carcinoma: a meta-analysis. Scandinavian Journal of Gastroenterology 2017; 52(2): 143 doi: 10.1080/00365521.2016.1236396
|
| 17 |
Adrian M. Di Bisceglie. Pretransplant treatments for hepatocellular carcinoma: Do they improve outcomes?. Liver Transplantation 2005; 11(S2): S10 doi: 10.1002/lt.20598
|
| 18 |
Ashwini Arvind, Karim Seif El Dahan, Riya Malhotra, Darine Daher, Nicole E. Rich, Madhukar S. Patel, Lisa B. VanWagner, Sarah R. Lieber, Thomas G. Cotter, Jeremy Louissaint, Arjmand R. Mufti, Laura Kulik, Anjana Pillai, Neehar D. Parikh, Amit G. Singal. Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis. Liver Transplantation 2024; 30(6): 595 doi: 10.1097/LVT.0000000000000357
|
| 19 |
A. H. Stockland, E. M. Walser, R. Paz-Fumagalli, J. M. McKinney, G. R. May. Preoperative Chemoembolization in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation: Influence of Emergent Versus Elective Procedures on Patient Survival and Tumor Recurrence Rate. CardioVascular and Interventional Radiology 2007; 30(5): 888 doi: 10.1007/s00270-007-9111-9
|